body radiation therapy of non-small cell lung cancer. J Thorac Oncol 2:S115-S117, 2007 10. Timmerman R, Galvin J, Pass H, et al: RTOG 0618: A Phase II Trial of Stereotactic Body Radiation Therapy in the Treatment of Patients With Operable Stage I/II Non-Small Cell Lung Cancer. Philadelphia, PA, Radiation Therapy Oncology Group, 2007, p 67 11. Hurkmans CW, Cuijpers JP, Lagerwaard FJ, et al: Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: Report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Radiat Oncol 4:1, 2009 12. Dawood O: M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife Radiosurgery for Operable Lung Cancer Patients. http://www.accuray. com/PressReleases.aspx?release 676 13. Grills IS, Mangona VS, Welsh R, et al: Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non–small-cell lung cancer. J Clin Oncol 28:928-935, 2010 14. Ginsberg RJ, Rubinstein LV: Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60:615-622, 1995; discussion 622-623 15. Reed CE, Harpole DH, Posther KE, et al: Results of the American College of Surgeons Oncology Group Z0050 trial: The utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg 126:1943-1951, 2003 16. Cerfolio RJ, Bryant AS: Survival of patients with true pathologic stage I non-small cell lung cancer. Ann Thorac Surg 88:917-922, 2009; discussion 922-923 17. Lee Y, Auh SL, Wang Y, et al: Therapeutic effects of ablative radiation on local tumor require CD8 T cells: Changing strategies for cancer treatment. Blood 114:589-595, 2009